CHRISTOPHER LANCTIN: Open Payments
NPI 1093348542 · ROBBINSDALE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 22 payments from 16 companies in 2025. Trend: 2023 $531 · 2024 $660 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $114 |
| Janssen Biotech, Inc. | 2 | $100 |
| ABBVIE INC. | 3 | $50 |
| Blue Earth Diagnostics | 2 | $33 |
| Antares Pharma, Inc. | 2 | $32 |
| Boston Scientific Corporation | 1 | $28 |
| Caris MPI, Inc. | 1 | $24 |
| Olympus America Inc. | 1 | $21 |
| Dendreon Pharmaceuticals LLC | 1 | $21 |
| 180 Medical, Inc. | 1 | $19 |
Products named: Xtandi, RYBREVANT, BOTOX, POSLUMA, XYOSTED, ERLEADA, Axonics, MI CANCER SEEK.
Industry payments across MN — which companies pay providers there.
